Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-18-007434
Filing Date
2018-04-02
Accepted
2018-04-02 17:06:08
Documents
4
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A odt-10ka_20171231.htm 10-K/A 569587
2 EX-31.1 odt-ex311_27.htm EX-31.1 17258
3 EX-31.2 odt-ex312_25.htm EX-31.2 17164
4 EX-32.1 odt-ex321_26.htm EX-32.1 14438
  Complete submission text file 0001564590-18-007434.txt   619680
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

EIN.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38318 | Film No.: 18729968
SIC: 2834 Pharmaceutical Preparations